A Cambridge startup is using Google Glass to teach children with autism how to better engage and socialize with people. Martha Herbert, assistant professor of neurology at Massachusetts General Hospital, will direct the upcoming clinical trial of the device.
Boston-Cambridge is ground zero for the development and deployment of many of the bleeding edge life science discoveries and technologies. One corner alone, Vassar and Main Street in Cambridge, will likely generate 1 to 2 percent of the future world GDP. The following HMS faculty are cited: George Church, Eric Lander, Robert Langer, Doug Melton, David Reich, Jack Szostak and Ting Wu.
Long-term use of the newer anti-clotting drug Brilinta cut heart attack survivors’ future risk of heart attack, stroke or heart-related death, a new study found. Marc Sabatine, a professor of medicine at Brigham and Women’s Hospital, led the study.
Experts in analytical testing say the New York Attorney General’s office may have used the wrong kind of test when it announced in its headline-grabbing investigation in February that store-brand herbal supplements sold by GNC, Target, Walmart and Walgreens contained little to none of the substances their labels claimed. Pieter Cohen, assistant professor at Cambridge Health Alliance, is quoted.
Nearly all of the limited healthcare resources of Liberia, Guinea, and Sierra Leone were diverted last year to cope with the Ebola crisis, leading to a drop in vaccination rates that could portend bigger measles outbreaks in the future, according to a study published this week. Paul Farmer, Kolokotrones University Professor of Global Health and Social Medicine and head of the Department of Global Health and Social Medicine, is quoted.
If Congress increases the tobacco purchase age to 21 from 18, it will “substantially” reduce the number of 15- to 17-year-olds who begin smoking, according to the results of an independent study conducted for the U.S. Food and Drug Administration. Jonathan Winickoff, associate professor of pediatrics at Massachusetts General Hospital, is mentioned.
Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines. Robert Green, associate professor of medicine at Brigham and Women’s Hospital, is quoted.
